Detalles de la búsqueda
1.
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity.
J Clin Immunol
; 43(4): 680-691, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36795264
2.
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases.
J Autoimmun
; 131: 102866, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35841684
3.
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups.
J Autoimmun
; 125: 102744, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34781162
4.
Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2.
Ann Rheum Dis
; 81(3): 441-443, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34819272
5.
Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia.
Hepatology
; 64(5): 1473-1482, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27483451
6.
Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: a prospective, controlled, open-label, cohort study.
Hepatology
; 61(4): 1145-53, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25431357
7.
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study.
J Autoimmun
; 63: 88-93, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26255249
8.
Assessment of free light chains in HCV-positive patients with mixed cryoglobulinaemia vasculitis undergoing rituximab treatment.
Liver Int
; 35(9): 2100-7, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25800731
9.
Assessment of liver stiffness in patients with HCV and mixed cryoglobulinemia undergoing rituximab treatment.
J Transl Med
; 12: 21, 2014 Jan 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-24456582
10.
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase.
J Transl Autoimmun
; 7: 100212, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37854035
11.
Virological and Clinical Response to Interferon-Free Regimens in Patients with HCV-Related Mixed Cryoglobulinemia: Preliminary Results of a Prospective Pilot Study.
Curr Drug Targets
; 18(7): 772-785, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-26853322
12.
Hepatitis B virus related cryoglobulinemic vasculitis: A multicentre open label study from the Gruppo Italiano di Studio delle Crioglobulinemie - GISC.
Dig Liver Dis
; 48(7): 780-4, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27106525
13.
Combined treatment with antiviral therapy and rituximab in patients with mixed cryoglobulinemia: review of the literature and report of a case using direct antiviral agents-based antihepatitis C virus therapy.
Case Reports Immunol
; 2015: 816424, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25815218
14.
Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: a prospective, controlled pilot study.
Dig Liver Dis
; 46(9): 833-7, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24953206
15.
Role of microRNA profile modifications in hepatitis C virus-related mixed cryoglobulinemia.
PLoS One
; 8(5): e62965, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23650540
Resultados
1 -
15
de 15
1
Próxima >
>>